Expedited safety reports should comply with regulatory requirements and which ICH guideline?

• A. ICH Guideline for Clinical Safety Data Management: Definitions and Standards for Expedited Reporting
• B. ICH E6(R2) Good Clinical Practice
• C. ICH E9 Statistical Principles for Clinical Trials
• D. ICH Q7 GMP for Active Pharmaceutical Ingredients

Answer: (A)

Expedited safety reporting is governed by a defined set of definitions and timelines so regulators receive safety information consistently and promptly. The guideline that provides these exact definitions and standards for expedited reporting in clinical safety data management is the correct reference. It specifies what qualifies as an expedited report, who must report, and the required timeframes, aligning with regulatory expectations for safety communications.

Other guidelines address different areas of clinical research. The general Good Clinical Practice guideline covers overall trial conduct and responsibilities but does not provide the detailed standards for expedited safety reporting. The statistical Principles guideline focuses on study design and analysis, not reporting workflows. GMP for active pharmaceutical ingredients deals with manufacturing quality, not clinical safety data reporting.